Last reviewed · How we verify
NCT06912308
Effect of Physiotherapy Methods on Functional and Respiratory Outcomes in ICU Patients With Respiratory Failure
NA trial testing Active Physiotherapy in Respiratory Insufficiency in 150 participants. Participants enrolled and being followed up; not accepting new ones.
30 September 2026
Quick facts
| Lead sponsor | Laura Rutkauskienė |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 150 |
| Start date | 30 September 2023 |
| Primary completion | 30 September 2026 |
| Estimated completion | 30 September 2027 |
| Sites | 1 location across Lithuania |
Drugs / interventions tested
- Active Physiotherapy
- Passive Physiotherapy
Conditions studied
- Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
Sponsor
Laura Rutkauskienė
Who can join
Adults 18 to 99, any sex, with Respiratory Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the biomedical study is to assess the changes in functional and qualitative indicators of critically ill patients with respiratory failure by applying different physiotherapy methods. By conducting this study and developing the "Physiotherapy Protocol for Critically Ill Patients Treated in the ICU," physiotherapists worldwide could be encouraged to work using a unified and adapted method. It is expected that the results, conclusions, and practical clinical recommendations derived from this study will be beneficial not only for rehabilitation specialists and intensivists in Lithuania but also for medical professionals working with respiratory diseases, including COVID-19 patients, at various stages of their treatment and consultation. Implementing an appropriate physiotherapy procedure protocol is anticipated to bring economic benefits, as early physiotherapy is safe and can reduce the incidence of delirium, decrease the duration of patient sedation, shorten the number of days on mechanical ventilation, and minimize hospital stay duration. Additionally, it aims to restore or improve patients' functional and independence levels, help prevent ICU-acquired weakness, and can be easily implemented in intensive care units.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Early mobilization, breathing exercises and chest wall oscillation in patients with bilateral pneumonia disease in the intensive care unit: a randomized clinical trial.
Rutkauskienė L, Kubilius R, Tamošuitis T. · · 2025 · cited 1× · PMID 41286729 · DOI 10.1186/s12890-025-04028-7
Verify or expand the search:
- PubMed search for NCT06912308
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Insufficiency
Currently open trials in the same condition.
- NCT06653166 — Retrospective Data Analysis With the Aim to Determine the Success Rate of Endotracheal Intubation in the First Attempt i · active not recruiting
- NCT06483984 — Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout · NA · recruiting
- NCT05906030 — Diaphragm Dysfunction and Ultrasound Perioperatively · recruiting
- NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
- NCT06494215 — Comparison of Different Methods to Calculate Pendelluft by Electrical Impedance Tomography in Mechanically Ventilated Pa · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06912308 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Laura Rutkauskienė
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06912308.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing